SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001014763-19-000010
Filing Date
2019-08-09
Accepted
2019-08-09 17:28:56
Documents
31
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q 6-30-2019 form10-q_06302019.htm 10-Q 303962
2 EXHIBIT 31.1 6-30-2019 exhibit31-1_06302019.htm EX-31.1 10373
3 EXHIBIT 32.1 6-30-2019 exhibit32-1_06302019.htm EX-32.1 5478
  Complete submission text file 0001014763-19-000010.txt   1321877

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT amar-20190630.xml EX-101.INS 120476
5 XBRL TAXONOMY EXTENSION SCHEMA amar-20190630.xsd EX-101.SCH 18676
6 amar-20190630_cal.xml EX-101.CAL 15852
7 amar-20190630_def.xml EX-101.DEF 135858
8 amar-20190630_lab.xml EX-101.LAB 112053
9 amar-20190630_pre.xml EX-101.PRE 140244
Mailing Address AMARILLO BIOSCIENCES INC 4134 BUSINESS PARK DRIVE AMARILLO TX 79110-4225
Business Address AMARILLO BIOSCIENCES INC 4134 BUSINESS PARK DRIVE AMARILLO TX 79110-4225 (806) 376-1741
AMARILLO BIOSCIENCES INC (Filer) CIK: 0001014763 (see all company filings)

IRS No.: 751974352 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20791 | Film No.: 191013949
SIC: 2834 Pharmaceutical Preparations